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derivative from the Moroccan marine sponge
Haliclona viscosa
Belkassem El-Amraoui1*, Jean-Fançois Biard2 and Aziz Fassouane1,3Abstract
In the aim of searching for new antifungal products from marine origin, we have isolated a sphingosine derivative,
(9Z)-2-amino-docos-9-ene-1,3,13,14-tetraol (Haliscosamine) from the Moroccan sea sponge Haliclona viscosa using
bio-guided (antifungal) HPLC methods. The molecular structure of this compound was elucidated by spectrometric
techniques IR, UV, MS and NMR. The isolated metabolite showed a significant antifungal activity against
Cryptococcus and Candida species and a weak general toxicity in the brine shrimp lethality test. Further research is
needed to study its in vivo activity, as well as to elucidate the mechanism underlying its activity in the hope of a
future use in medical mycology.
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Our laboratory aims to find new antifungal metabolites
from marine origin for use in human medicine on one
hand, and on the other hand in phytopathology. Marine
invertebrates of Moroccan Atlantic coast are our preferred
source of producers of active substances, specifically
sponges, known generally to contain secondary metabo-
lites with interesting biological activities (Faulkner 2002)
including antimicrobial (Baker et al. 2009), antifungal
(Clark et al. 2001), antileishmanial (Dube et al. 2007), anti-
oxidant (Regoli et al. 2004) and cytotoxic activities (Ayyad
et al. 2009, Fusetani et al. 1989, Erickson et al. 1997,
Rashid et al. 2000). In the first work (El-Amraoui et al.
2010), we screened antifungal activity in hydroalcoholic
and organic extracts of 14 sponges and showed that three
species of them are active against pathogenic fungi and
bacteria: Haplosclerida adocia, Cinachyrella tarentina and
Haliclona viscosa. This latter species being shown the
most active, we chose it to isolate the active compound.
Kupchan partitioning, then multistep HPLC from the
organic extract provided a pure active product. We deter-
mined its structure and evaluated its antifungal potential
and its toxicity.* Correspondence: elamraouibelkassem@yahoo.fr
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Isolation of the active product
Lyophilized sponge (800 g) was extracted with EtOH,
the extract partitioned between CH2Cl2 and H2O, and
the organic solution submitted to a Kupchan liquid par-
tition procedure. EtOAc and MeOH:H2O fractions were
pooled, then the mixture was successively separated by
three steps of HPLC to yield 47 mg of an amorphous
pale yellow product. All steps of this isolation were
bio-guided by antifungal (agar disc-diffusion) test. The
total mass of the product (taking into account other
fractions containing isolated compound) was estimated
to be 80 mg from 800 g of dry sponge (0.01%).Molecular structure of the product isolated from
Haliclona viscosa
The molecular formula of the compound was determined
to be C22H45NO4, indicating one degree of unsaturation, by
HRESIMS with the molecular ion peaks at m/z 410.3255
([M + Na]+) for C22H45NO4Na (calculated 410.32463,
δ 2ppm), and m/z 388.3431 ([M + H]+) for C22H46NO4
(calculated 388.34268, δ 1ppm) in positive ion mode.
MS analysis of the product ([M + H]+, 388) showed
fragments at 370, 352, 334, 316 for the loss of four –OH,
and 299 for the –NH2. Same analysis was done with the
acetylated product showing a [M + Na]+ ion at m/z 620s is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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at 560, 500, 440 and 380 for the losses of four acetyl moi-
eties (Figure 1). No ion at 320 for a fifth acetyl was
observed.
The UV spectrum (in MeOH) (Figure 2) showed weak
absorptions (δ = 1178 at 207.5 nm and δ = 228 at
281.0 nm).
The IR spectrum (Figure 3) showed absorptions at 3358,
1065 and 1048 (hydroxyl), 2926 and 2855 (aliphatic), 1659
and 1630 cm-1 (double bond). No peak was visible for a
carbonyl function.
Analysis of 1H (Figure 4), 13C (Figure 5) and HSQC (in
deuterated methanol CD3OD) (Figure 6) experiments
revealed the presence of 22 carbons with 39 protons, in-
cluding one methyl, 15 methylens and six methines.
Table 1 shows NMR spectroscopic data of compound.
The presence of four oxygenated C atoms at 59.11 (C-1),
67.72 (C-3), 73.36 (C-13), 73.81 (C-14), a probably
nitrogenated C atom at 57.72 (C-2), and two doubleFigure 1 Masse spectrum of acetylated compound.bonded carbons at 129.08 (C-9) and 129.82 (C-10) were
elucidated. General appearance of the NMR spectra sug-
gested that it is a derivative of the sphingosine. There-
fore, the six remaining protons should correspond to
one –NH2 and four –OH. From the careful examination
of the 2D NMR experiments spectra (HMQC, HMBC
(Figures 7, 8, 9 and 10), COSY (Figures 11 and 12),
TOCSY (Figure 13)), three different structural units
were identified: C-1 to C-5, C-8 to C-16 and C-20 to C-
22 (Figure 14). However, respective positions of the car-
bons 9/10, 8/11 and 13/14 were not clear because there
was a strong overlapping of their signals on the 1H-
NMR spectrum. Experiments with other solvents were
limited by the poor solubility of compound in AcN,
CH2Cl2 and CHCl3. Finally, the assignments of the
1H-
NMR signals were determined by recording a new set of
experiments with increased resolution for the corre-
sponding areas, and by extensive 1H-NMR decoupling
experiments (Figures 15, 16, 17 and 18). Consequently,
Figure 2 UV-spectrum of haliscosamine.
Figure 3 IR spectrum of haliscosamine.











Figure 4 1H NMR spectrum of haliscosamine.
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for these three partial structures.
Assemblage of the three sub-structures was done
by supplementary 1H-NMR decoupling experiments,
which allow to link C-22 to C-21 and C-20, then to
C-16 by the way of the three CH2 at 29.17, 29.18 and29.20 (10, 9, 8 respectively). Accordingly, the two last
remaining –CH2 (C-6 and C-7) should be positioned
between C-5 and C-8 to complete the structural eluci-
dation of compound. Geometry of the double bond was
assigned to be Z on the basis of the 1H-NMR experiments:













































Figure 5 13C NMR spectrum of haliscosamine.
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olefinic protons group and allowed to found a 10 Hz
coupling constant for these protons. Recording of
other 1H-NMR spectrum in CD3OD with some drops
of deuterated benzene (C6D6) (Figure 21) increases the
resolution and allowed confirming this 10 Hz coupling
constant. The geometry of the double bond was confirmedby the weak difference between the chemical shifts values
of the carbons C-8 (26.77) and C-11 (23.32).
The optical rotation was [α]20D = 22,3 (c = 0,76, MeOH).
The compound isolated from H. viscosa: (9Z)-
2-amino-docos-9-ene-1,3,13,14-tetraol (Figure 22), is a
new sphingosine derivative. Therefore, we named this
product haliscosamine.
Figure 6 HSQC spectrum of haliscosamine.
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Antifungal activity
In vitro antifungal activity and minimal inhibitory concen-
tration (MIC90) of haliscosamine against the pathogenic
yeasts were reported in Tables 2 and 3 respectively.
The in vitro antifungal activity by the diffusion method
showed that haliscosamine was more active than nysta-
tin in inhibiting the growth of Cryptococcus neoformans
(ATCC 11576), but showed the same activity as nystatin
in inhibiting the growth of C. albicans (ATCC 10231).
On the other hand, haliscosamine was active against
C. tropicalis (R2 CIP 1275.81), an amphotericin B and
nystatin resistant strain.
The MIC90 of haliscosamine is less than that of nystatin
on C. neoformans. and C. albicans, and the same level as
the previous in C. tropicalis.Toxicity test
Lethality concentration (24 h-LC50 value) for haliscosamine
is 664.86 μg/mL. This general toxicity activity is considered
weak when the LC50 was between 500 and 1000 μg/mL,
moderate when the LC50 was between 100 and 500 μg/mL,
and designated as strong when the LC50 ranged from 0 to100 μg/mL (Padmaja et al. 2002, Canales et al. 2007).
Consequentely, the toxicity of the haliscosamine may be
considered as weak by this test.
Discussion
Haliscosamine isolated from the Moroccan marine sponge
Haliclona viscosa is a new derivative of sphingosine with
an original molecular structure ((Z)-2-amino-docos-9-
ene-1,3,13,14-tetraol, C22H45NO4). However, the relative
and absolute stereochemistries of the molecule remain to
be determined, with confirmation by total synthesis.
The high content (0.01%) of the haliscosamine in the
sponge, as its presence in the free state and not involved
in a ceramide or other complex lipid is remarkable. The
haliscosamine is added to products already isolated from
sponges of the genus Haliclona, such the alkaloids
viscosamine (Volk and Kock 2003), viscosaline (Volk and
Kock 2004) and haliclamines A, B, C and D (Fusetani
et al. 1989, Volk et al. 2004). The activity of this product
also shows the bioactive potential of marine sponges from
the Atlantic Coast of Morocco, and encourages them to
continue our sorting activity. The only study that has been
done before has been the isolation of untenospongin B
(antimicrobial) from the marine sponge Hippospongia
Table 1 NMR spectroscopic data for haliscosamine
Carbon δ13C ppm δ 1H ppm J(Hz) HMBC COSY TOCSY
1a 59.12, CH2 3.67dd (J = 11.7, 4.0) 2, 3 1b, 2, 3 2, 3
1b 3.79dd (J = 11.7, 4.0) 2, 3 1a, 2, 3 2, 3
2 57.72, CH 3.07 m (J = 6.8, 4.0) 1, 3, 4 1 1, 3
3 67.72, CH 3.69 m (J = 6.8, 4.0) 1, 2, 4, 5 1, 4 1, 2, 4, 6
4a 33.51, CH2 1.47 m 2, 3, 5
4b 1.57 m 2, 3, 5
5a 24.92, CH2 1.40 m 3
5b 1.57 m 3
6 28.94, CH2 1.37 m
7 29.45, CH2 1.37 m 8 8 9
8 26.77, CH2 2.09 m 7, 9 7, 9, 10
9 129.08, CH 5.39 m 8 8, 10 8, 7
10 129.82, CH 5.40 m 11 8, 9, 11 11, 13
11a 23.32, CH2 2.13 m 10, 12, 13 10, 12 10, 13
11b 2.24 m 10, 12, 13 10, 12 10, 13
12a 32.59, CH2 1.54 m 11, 13 13
12b 1.59 m 11, 13 13
13 73.37, CH 3.42 11, 12, 14, 15 10, 11, 12, 15
14 73.81, CH 3.40 13, 15, 16 15
15a 32.67, CH2 1.44 m 13, 14, 16 14 13
15b 1.54 m 13, 14, 16 14 13
16a 25.64, CH2 1.37 m 14, 15
16b 1.52 m 14, 15
17 29.17, CH2 1.37 m
18 29.18, CH2 1.37 m
19 29.20, CH2 1.37 m
20 31.66, CH2 1.33 m 21, 22
21 22.32, CH2 1.36 t (J = 6.5) 20, 22
22 13.06, CH3 0.92 20, 21
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and inhibitor of lymphocyte proliferation) isolated from
Ircinia variabilis (Rifai et al. 2005).
Haliscosamine has a remarkable antifungal effect.
Sphingolipids are already known for their antiseptic and
antifungal activity (Bibel et al. 1995), and sphingosine
and its derivatives are natural antimicrobial agents,
protecting the human skin from bacterial colonization
(Bibel et al. 1993) as well as being anti-inflammatory
agents (Radhika et al. 2005).
Compared to nystatin, haliscosamine showed in vitro
significant activity against Candida albicans (ATCC
10231),Candida tropicalis (CIP 1275.81) and Cryptococcus
neoformans (ATCC 11576). These three yeasts are often
involved in human mycology especially C. tropicalis that is
resistant to nystatin and amphotericin B.Comparing the antifungal activity of haliscosamine with
(-)-untenospongin B isolated from the marine sponge
Hippospongia communis collected from the Atlantic Coast
of Morocco (Rifai et al. 2004), it was found that halisco-
samine was more active than untenospongin B in inhi-
biting the growth of C. tropicalis (R2 CIP 1275.81), C.
albicans (ATCC 10231) and C. neoformans (ATCC 11576)
(Table 2). So, haliscosamine is an interesting product,
thanks to its antifungal potential against strains involved
in human mycology, including those resistant to nystatin.
Further studies are still needed to determine in vivo acti-
vity and toxicity of haliscosamine in the animal model as
well as to elucidate the mechanism underlying its activity.
The lethal concentration (24 h-LC50 = 664.86 μg/mL) of
haliscosamine is greater than 500 μg/mL, so the general
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Figure 7 1H-13C HMBC spectrum of haliscosamine (MEOD).
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date to assess more fully for a development of a new drug
for the treatment of fungal infections.Materials and methods
Biological marine material
The marine sponge (Ref. EM14) H. viscosa (Topsent,
1888) was collected from the Atlantic coast of El-Jadida
city, Morocco (N 33 15 422, W 008° 29 722)
(El-Amraoui et al. 2010). The sponge was identified by
Dr. Maria-Jesús Uriz, Research Professor at the Centro de
Estudios Avanzados de Blanes(CEAB), Spain. After collec-
tion, the sponge was immediately cut into small pieces,
washed with sterile distilled water, then frozen at -30°C for
two days and immediately freeze-dried to give a lyophi-
lized material ready for extraction.General experimental procedures
Freeze-dryer was a FreeZone2.5Plus type (Labconco,
USA).TLC was carried out on precoated Macherey-Nagel
Alugram silica, and spots were visualized by spraying with
iodine vapor or ninhydrine reagents.
The UV spectrum was recorded on a Helios Omega
spectrophotometer (Thermo Scientific, France).
The IR spectrum was obtained on a spectrometer IR-FT
Paragon 1000 PC (Perkin-Elmer, USA).
The NMR spectra (1H, 13C, HSQC, HMBC, COSY and
TOCSY experiments) were recorded on a Bruker 500
with a TXI cryosonde (PRISM, Rennes University, France)
and a Bruker Avance 500 (CRMPO, Rennes University,
France) for in-deep 2D experiments and irradiations
tests.
HRESIMS data were recorded on a Micromass Zab
Spec Tof (CRMPO, Rennes University, France). ESIMS
data of the acetylated product was recorded on a
Finnigan LCQ mass spectrometer (IFREMER, Nantes,
France).
Optical rotation was measured on a Schmidt + Haensch
Polartronic NH8 polarimeter.
Acetylation: 1 mg of isolated product was treated with
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Figure 8 1H-13C HMBC spectrum of haliscosamine (MEOD).

















Figure 9 1H-13C HMBC spectrum of haliscosamine (MEOD).














Figure 10 1H-13C HMBC spectrum of haliscosamine (MEOD).
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was added and the mixture extracted with diethyl-ether
(4 × 10 mL) to afford 1.2 mg of acetylated product.Extraction and isolation
The sample (800 g of lyophilized sponge) was homoge-
nized with ethanol 80% (1 × 1000 mL), allowed to stand in
a dark chamber for 24 h and filtered. The residue was
again extracted with absolute ethanol (2 × 1000 mL). Both
ethanolic extracts were combined, and then evaporated at
reduced pressure until total evaporation of ethanol. The
resulting aqueous suspension was completed with distilled
water to 1000 mL as final volume and extracted with
CH2Cl2 (3 × 500 mL). The CH2Cl2 solutions werecombined, dried on anhydrous sodium sulphate
(Na2SO4), filtered and concentrated at reduced pressure
to give a dichloromethane extract (3 g).
This extract was fractioned by modified Kupchan
method: 3 g were dissolved in 300 mL of MeOH:H2O
(9:1 v/v) and extracted with 3 × 150 mL of hexane (A)
(1.5 g). The remaining solution was adjusted with distilled
water to get the proportions 6:4 v/v, then extracted with
3 × 150 mL of dichloromethane (B) (0.3 g) and then with
3 × 150 mL of ethyl acetate (C) (0.7 g). The residue was
lyophilized (D) (0.5 g).
Fractions C and D were combined (1.2 g), applied on
silica gel 60 (25 g) column, and eluted with successive
mixtures (110 mL) of CHCl3: MeOH (10:0; 9:1; 8:2; 7:3;
6:4; 4:6 and 0:10 v/v) to yield nine fractions. Fractions 4, 5











Figure 11 1H-1H COSY spectrum of haliscosamine.
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preparative HPLC diol column (Inertsil Diol L10OH.25R,
10 × 250 mm, 10 μm) by a CH2CL2: MeOH (8.5:1.5 v/v)
isocratic mixture. Purification of subfractions 2 (95 mg) by
HPLC C18 column (Inertsil ODS-3, 4.6 × 250 mm, 5 μm)
with isocratic MeOH:H2O (6.5:3.5 v/v) gave 47 mg of a
pure active product.
Microorganisms
The fungal species obtained from the Fungi Culture
Collection (FCC) of the National Cultures Collection of
Microorganisms of the Pasteur Institute, Paris, France,from the Collection of Institut Pasteur (CIP) and from the
American Type Culture Collection (ATCC) were used as
the antifungal test strains: Candida albicans (ATCC
10231), Candida tropicalis (R2 CIP 1275.81, an ampho-
tericin B and nystatin resistant strain), Cryptococcus
neoformans (ATCC 11576). The yeasts were maintained on
the Sabouraud’s agarmedium at 28°C.
Antifungal activity
The antifungal activity was assessed in vitro by agar disc-
diffusion test. The minimum inhibitory concentration was
evaluated by the microdilution method.
Figure 12 Detail of 1H-1H COSY spectrum of haliscosamine.
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This test usesYeastMorphological Agar (YMA) as medium
[yeast nitrogen base (Difco) 60.5 g/L; asparagin (Prolabo)
1.5 g/L; glucose (Merck) 10 g/L and agar (Merck) 20 g/L].
The suspensions of yeast were adjusted in sterile water to
match the density of a 0.5 McFarland Standard. Each disk
received 100 μg of sponge extract and was applied on the
test media which were previously inoculated with each test
strain. Plates were first kept at 4°C for at least two hours to
allow the diffusion of chemicals, and then incubated
at 28°C. Inhibition zones were measured after 24 h ofincubation (Galeano and Martínez 2007). Standard disks of
nystatin (100 μg) served as positive antifungal control. All
the assays were carried out in triplicate.Minimum inhibitory concentration (MIC)
The MIC90 (the lowest concentration causing at least
90% of growth inhibition when compared to drug-free
control) of the isolated compound was measured using
the method described by Rifai et al. (2005). Yeast Mor-
phological Broth medium was used as test media. Tests
Figure 13 TOCSY spectrum of haliscosamine.
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Figure 14 The three sub-structures of haliscosamine. (a) C-1 to C-6, (b) C-8 and C-16 (c) C-20 to C-22.
6 - doublet
Figure 15 1H spectrum of haliscosamine (MEOD, irradiation at δ 1.369 ppm).
3 6
Figure 16 1H spectrum of haliscosamine (MEOD, irradiation at δ 5.398 ppm).
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Figure 17 1H spectrum of haliscosamine (MEOD, irradiation at δ 1.523 ppm).
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Figure 19 1H spectrum of haliscosamine (MEOD, irradiation at δ 2.09).
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Figure 18 1H spectrum of haliscosamine (MEOD, irradiation at δ 3.415 ppm).
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Figure 22 Molecular structure of haliscosamine [(9Z)-2-amino-docos-9-ene-1,3,13,14-tetraol].
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Table 2 In vitro antifungal activity of haliscosamine and
nystatin against pathogenic yeasts







C. neoformans 28 24 0
C. albicans 25 25 17
C. tropicalis 25 0 5
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plates. The suspensions of yeast were adjusted in sterile
water to match the density of a 0.5 McFarland Standard.
The wells of a microdilution plate were inoculated with
180 mL of the culture medium containing a final inocu-
lum of 0.5 - 2.5 103 CFU/mL. The test drug and positive
control (nystatin) previously solubilized in dimethyl-
sulphoxide (DMSO) were serially diluted two fold in the
liquid medium to give a range of concentration from
640 to 0.1 μg/mL. Twenty μL of each concentration
were added to wells containing culture suspension ex-
cept the growth control well. The final concentration
ranged from 64 to 0.01 μg/mL. Plates were incubated at
35°C for 48 h. Fungal growth was assessed at 494 nm by
measuring the optical density in each well using an en-
zyme immunoassay multiwell reader (Sigma diagnostic).
The test was carried out in triplicate.
Brine shrimp toxicity test
Hatching shrimp
Brine shrimp eggs (Artemia salina) are hatched in artifi-
cial seawater prepared by dissolving sea salt in distilled
water (38 g/L) during 48 h incubation in a warm room
(22 - 29°C). Seawater is placed in a small unequally
divided tank and shrimp eggs are added to the larger
compartment of the tank which is covered by aluminium
foil to darken it. The illuminated compartment attracts
shrimp larvae (nauplii) through perforations in the dam
(Meyer et al. 1982).
Brine shrimp microwell toxicity assay
The toxicity of haliscosamine was monitored by the
brine shrimp lethality test. Samples were dissolved in
DMSO and diluted with sea water so that the finalTable 3 Minimum Inhibitory Concentration (MIC90) of
haliscosamine and nystatin against pathogenic yeasts
Test organism Minimum inhibitory concentration (μg/mL)
Haliscosamine Nystatin
C. neoformens 0.2 – 0.4 3.12 – 6.25
C. albicans 0.4 – 0.8 3.12 – 6.25
C. tropicalis 0.4 – 0.8 0concentration of DMSO did not exceed 0.05%. Serial di-
lutions (2000, 200 and 20 μg/mL) of samples were made
in wells of 96-well microplates in triplicate in 100 μL of
sea water (Rahman et al. 2001). The last row was left
with sea water and DMSO only served as the drug free
control. 100μL of suspension of nauplii containing about
10 larvae were added into each well and incubated for
24 h at 22-29°C. The plates were then examined under a
binocular microscope (× 12.5) and the number of dead
nauplii in each well was counted. One hundred μL of
methanol were then added and after 10 min, the total
numbers of shrimp in each well was counted and
recorded. Lethality concentration fifties (LC50 values) for
each assay were calculated by taking the average of the
three experiments using a Finney Probit analysis pro-
gram on an IBM computer.
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